National Health & Safety Clarifies Earlier Announcement
PR Newswire - January 06, 1999 17:26
WARMINSTER, Pa., Jan. 6 /PRNewswire/ -- National Health & Safety Corporation (OTC Bulletin
Board: NHLT) announced today a clarification of one portion of the press release made earlier today
by the company that it was in the final stages of negotiation for financing.
Dr. Dennis Bowers, CEO of National Health & Safety, said that the press release included a
statement that the Longport Digital Scanner technology for which National Health & Safety has
obtained exclusive North American marketing rights "can detect various forms of cancer without the
need for invasive surgery."
Bowers said that the wording regarding the Longport Digital Scanner was accidentally and
prematurely released. A clinical trial is currently underway at Thomas Jefferson University Department
of Radiology, Division of Ultrasound, Philadelphia, PA to study "High Resolution Skin Ultrasound for
Evaluating Patients with known Primary Melanoma for Satellite or intransit Metastases." Therefore,
Bowers said, it has yet to be proven that the "LDS" can detect skin cancer cells. There are other
areas of application currently being tested for the LDS technology including breast pathology. Bowers
said that the responsibility for the error in wording in the first press release was totally the
responsibility of National Health & Safety and did not result from information received from Longport,
Inc. (OTC symbol "LPTI").
SOURCE National Health & Safety Corporation
/CONTACT: Kerri A. Millar of National Health & Safety, 215-442-0926/ |
